Literature DB >> 17174946

Hepatocyte growth factor activator inhibitor-1 (HAI-1) is essential for the integrity of basement membranes in the developing placental labyrinth.

Bin Fan1, Jane Brennan, Deanna Grant, Franklin Peale, Linda Rangell, Daniel Kirchhofer.   

Abstract

Hepatocyte growth factor activator inhibitor-1 (HAI-1) is a membrane-associated Kunitz-type serine protease inhibitor that regulates cell surface and extracellular serine proteases involved in tissue remodeling and tumorigenesis, such as HGFA, matriptase, prostasin and hepsin. We generated HAI-1 deficient mice, which died in utero due to placental defects. The HAI-1(-/-) placental labyrinth exhibited a complete failure of vascularization and a compact morphology of the trophoblast layer. Immunofluorescent staining of collagen IV and laminin and electron microscopy analysis revealed that this aberrant labyrinth architecture was associated with disrupted basement membranes located at the interface of chorionic trophoblasts and allantoic mesoderm. Unlike the placental labyrinth, basement membranes and vasculogenesis were normal in embryo and yolk sac. Therefore, basement membrane defects appear to be the underlying cause for the greatly impaired vascularization and trophoblast branching in HAI-1(-/-) placentas. In wild-type placentas, the expression of matriptase and prostasin co-localized with their physiological inhibitor HAI-1 to the labyrinthine trophoblast cells in proximity to basement membranes. In HAI-1(-/-) placentas, both the localization and expression of the two proteases remained unchanged, implying uncontrolled proteolytic activities of the two enzymes. Our study demonstrates the important role of HAI-1 in maintaining the integrity of basement membrane most likely by regulating extracellular proteolytic activities during placental development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17174946     DOI: 10.1016/j.ydbio.2006.11.005

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  29 in total

1.  Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.

Authors:  Roman Szabo; John P Hobson; Karin List; Alfredo Molinolo; Chen-Yong Lin; Thomas H Bugge
Journal:  J Biol Chem       Date:  2008-08-19       Impact factor: 5.157

Review 2.  Membrane-anchored serine proteases in vertebrate cell and developmental biology.

Authors:  Roman Szabo; Thomas H Bugge
Journal:  Annu Rev Cell Dev Biol       Date:  2011-06-29       Impact factor: 13.827

3.  The crystal structure of a multidomain protease inhibitor (HAI-1) reveals the mechanism of its auto-inhibition.

Authors:  Min Liu; Cai Yuan; Jan K Jensen; Baoyu Zhao; Yunbin Jiang; Longguang Jiang; Mingdong Huang
Journal:  J Biol Chem       Date:  2017-03-27       Impact factor: 5.157

Review 4.  The role of type II transmembrane serine protease-mediated signaling in cancer.

Authors:  Lauren M Tanabe; Karin List
Journal:  FEBS J       Date:  2016-12-24       Impact factor: 5.542

5.  Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.

Authors:  Kazuyo Kohama; Makiko Kawaguchi; Tsuyoshi Fukushima; Chen-Yong Lin; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2012-12-18       Impact factor: 4.174

6.  Expression of hepatocyte growth factor activator inhibitor type 1 on the epithelial cell surface is regulated by hypoxic and oxidative stresses.

Authors:  Wataru Komaki; Tsuyoshi Fukushima; Hiroyuki Tanaka; Hiroshi Itoh; Etsuo Chosa; Hiroaki Kataoka
Journal:  Virchows Arch       Date:  2008-09-04       Impact factor: 4.064

7.  Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality.

Authors:  Roman Szabo; Peter Kosa; Karin List; Thomas H Bugge
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

8.  A Grhl2-dependent gene network controls trophoblast branching morphogenesis.

Authors:  Katharina Walentin; Christian Hinze; Max Werth; Nadine Haase; Saaket Varma; Robert Morell; Annekatrin Aue; Elisabeth Pötschke; David Warburton; Andong Qiu; Jonathan Barasch; Bettina Purfürst; Christoph Dieterich; Elena Popova; Michael Bader; Ralf Dechend; Anne Cathrine Staff; Zeliha Yesim Yurtdas; Ergin Kilic; Kai M Schmidt-Ott
Journal:  Development       Date:  2015-03-15       Impact factor: 6.868

9.  Crystal Structure of a Two-domain Fragment of Hepatocyte Growth Factor Activator Inhibitor-1: FUNCTIONAL INTERACTIONS BETWEEN THE KUNITZ-TYPE INHIBITOR DOMAIN-1 AND THE NEIGHBORING POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN.

Authors:  Zebin Hong; Laura De Meulemeester; Annemarie Jacobi; Jan Skov Pedersen; J Preben Morth; Peter A Andreasen; Jan K Jensen
Journal:  J Biol Chem       Date:  2016-05-06       Impact factor: 5.157

10.  Tissue injury alters the site of expression of hepatocyte growth factor activator inhibitor type 1 in bronchial epithelial cells.

Authors:  Hiroyuki Tanaka; Tsuyoshi Fukushima; Kenji Yorita; Makiko Kawaguchi; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2009-02       Impact factor: 4.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.